Articles

Economic Report: U.S. consumer sentiment sags to 6-month low on worries over higher interest rates and Mideast war

U.S. consumer sentiment fell in November for the fourth month in a row due to worries about higher interest rates as well as ongoing war in the Middle East.

Earnings Results: China’s biggest chip maker reports near 80% profit drop, with exec warning of ‘gray rhino effect’

China chip foundry giant Semiconductor Manufacturing International Corp. reported plunging profits and sales on Friday.

Market Extra: Wall Street analysts are excited about this bullish stock-market indicator

A bullish stock market indicator with a sterling track record arrived last week. And technical analysts on Wall Street haven't stopped talking about it.

: Novo Nordisk, maker of Ozempic and Wegovy, to invest more than $6 billion to expand production

Drugmaker set to expand Danish facilities amid ongoing Wegovy shortage.

: Sir Jim Ratcliffe close to Manchester United minority deal, report says

British billionaire Sir Jim Ratcliffe is reportedly close to clinching a deal to become a minority stakeholder in Manchester United. 

: SoFi CEO Anthony Noto makes $300,000 stock purchase, and CFO buys as well

As SoFi shares slid this week, two executives bought up stock.

Europe Markets: Richemont stock leads declines in Europe’s luxury sector as slower growth and higher interest rates hit sales

Shares in Richemont led Europe's luxury goods sector lower on Friday, after the Swiss-based group said geopolitical angst and a weakening European economy had delivered lower than expected first-half profits.

Financial Crime: Scams targeting veterans are on the rise — here’s how to avoid them

Post Content

The Ratings Game: Plug Power’s stock plummets, as Wall Street can no longer wait for the bottom

Plug Power's stock plummeted Friday, after another disappointing quarterly report prompted some analysts to bag their bullish calls.

: Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say

Company will halt development of experimental depression treatment

The Ratings Game: Unity seen ‘traversing a perilous path’ as stock slides

"Unity's forward path is clouded with uncertainty," an analyst wrote after the latest earnings report.

Cannabis Watch: Curaleaf and Canopy Growth miss Q3 analyst marks while Ascend Wellness beats forecasts

Post Content
1 1,757 1,758 1,759 1,760 1,761 2,303